Skip to main content

How Therapeutic Hypothermia Could Benefit ICU Patients

recent study discovered how lower temperatures improved a surfactant’s activity, showing that therapeutic hypothermia is a possible treatment option for ARDS, which impacts roughly one-tenth of intensive care unit (“ICU”) patients globally. Apart from patients in ICUs, critical coronavirus patients also suffer from acute respiratory distress syndrome.

In layman’s language, therapeutic hypothermia is the intentional cooling of an individual’s body. Research conducted by Chiara Autilio and colleagues from the Jesus Perez-Gil laboratory at the Complutense University of Madrid demonstrates how therapeutic hypothermia works at the molecular level in an individual’s lungs; the research also notes how this method could effectively be applied to acute…

Read More >>

NOTE TO INVESTORS: The latest news and updates relating to AzurRx BioPharma Inc. (NASDAQ: AZRX) are available in the company’s newsroom at https://ibn.fm/AZRX

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.